These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2382 related items for PubMed ID: 9863414

  • 1. [Functional evaluation in patients with kidney calculi].
    Stojimirović B.
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK, Maloney ME, Mathias BJ, Pietrow PK, Preminger GM.
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [Abstract] [Full Text] [Related]

  • 5. Body size and 24-hour urine composition.
    Taylor EN, Curhan GC.
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [Abstract] [Full Text] [Related]

  • 6. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE, Odvina CV, Wuermser LA, Pak CY.
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [Abstract] [Full Text] [Related]

  • 7. Contributory metabolic factors in the development of nephrolithiasis in patients with medullary sponge kidney.
    Yagisawa T, Kobayashi C, Hayashi T, Yoshida A, Toma H.
    Am J Kidney Dis; 2001 Jun; 37(6):1140-3. PubMed ID: 11382681
    [Abstract] [Full Text] [Related]

  • 8. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A, Meola M, D'Alessandro C, Bernabini G, Pasquali E, Carpi A, Barsotti G.
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [Abstract] [Full Text] [Related]

  • 9. [Sodium excretion in children with lithogenic disorders].
    Kovacević L, Kovacević S, Smoljanić Z, Peco-Antić A, Kostić N, Gajić M, Kovacević N, Jovanović O.
    Srp Arh Celok Lek; 1998 Jan; 126(9-10):321-6. PubMed ID: 9863402
    [Abstract] [Full Text] [Related]

  • 10. [Identification of lithogenic risk factors by a simplified first-line laboratory assessment in urinary calculi patients].
    Glémain P, Prunet D.
    Prog Urol; 2006 Nov; 16(5):542-5. PubMed ID: 17175947
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of fasting hypercalciuria associated with increased citraturia in the ambulatory evaluation of nephrolithiasis.
    Damasio B, Massarino F, Durand F, Banchero R, Bottino P, De Franchis V, Carmignani G, Cannella G.
    J Nephrol; 2005 Nov; 18(3):262-6. PubMed ID: 16013013
    [Abstract] [Full Text] [Related]

  • 12. Alkaline citrate in prevention of recurrent calcium oxalate stones.
    Berg C.
    Scand J Urol Nephrol Suppl; 1990 Nov; 130():1-83. PubMed ID: 2291093
    [Abstract] [Full Text] [Related]

  • 13. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY, Sakhaee K, Fuller CJ.
    Trans Assoc Am Physicians; 1983 Nov; 96():294-305. PubMed ID: 6679957
    [Abstract] [Full Text] [Related]

  • 14. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W, Kochakarn W, Ruangraksa C, Domrongkitchaiporn S.
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [Abstract] [Full Text] [Related]

  • 15. [Nephrolithiasis--rational etiological assessment].
    Hess B, Ackermann D.
    Praxis (Bern 1994); 1997 Mar 25; 86(13):529-32. PubMed ID: 9157499
    [Abstract] [Full Text] [Related]

  • 16. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
    Siener R, Schade N, Nicolay C, von Unruh GE, Hesse A.
    J Urol; 2005 May 25; 173(5):1601-5. PubMed ID: 15821507
    [Abstract] [Full Text] [Related]

  • 17. Idiopathic recurrent calcium urolithiasis (IRCU): an acid meal challenge uncovers inappropriate pH of postprandial, fasting and daily urine: a cross-sectional study of male patients providing insight into post- and pre-load urinary stone substances, crystallization risk, presence of stones, renal transport and systemic metabolic factors.
    Schwille PO, Wipplinger J.
    Eur J Med Res; 2008 Jul 28; 13(7):332-42. PubMed ID: 18700191
    [Abstract] [Full Text] [Related]

  • 18. Simplified protocol for biochemical evaluation of recurrent renal calcium stone disease.
    Thode J, Finnerup B, Parvin C, Holmegaard SN, Skaarup P, Sørensen OH, Transbøl I.
    Miner Electrolyte Metab; 1988 Jul 28; 14(5):288-96. PubMed ID: 2845241
    [Abstract] [Full Text] [Related]

  • 19. Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
    Terribile M, Capuano M, Cangiano G, Carnovale V, Ferrara P, Petrarulo M, Marangella M.
    Nephrol Dial Transplant; 2006 Jul 28; 21(7):1870-5. PubMed ID: 16595587
    [Abstract] [Full Text] [Related]

  • 20. Prevention of recurrent nephrolithiasis.
    Goldfarb DS, Coe FL.
    Am Fam Physician; 1999 Nov 15; 60(8):2269-76. PubMed ID: 10593318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 120.